Amrize Net Income From Continuing Ops from 2010 to 2026

AMRZ Stock   55.62  -0.68  -1.21%   
Amrize's shows a recovering structural trend supported by multi-year data. Analyst models indicate potential upside toward approximately 1.2 B. Regression distribution of quarterly values from 2010 to 2026 reveals a arithmetic mean of 940,535,294 . with r-squared of 0.53 . View All Fundamentals
 
Net Income From Continuing Ops  
 First Reported
2010-12-31
 Previous Quarter
1.2 B
 Current Value
1.2 B
 Quarterly Volatility
177.1 M
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Financial statement trends for Amrize provide structured context on operating performance and capital structure. This context pairs drivers like Tax Provision of 385.4 M, Depreciation And Amortization of 913.9 M or Interest Expense of 371.8 M and ratios such as core financial ratios with Amrize Valuation and Volatility views.
  
Build AI portfolio with Amrize Stock
Amrize Correlation provides competitor comparison context for Amrize. The view supports competitor context.
Our How to Buy Amrize Stock guide explains the steps to invest in Amrize stock.
Analyzing Amrize's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing Amrize's current valuation and future prospects.

Latest Amrize's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Amrize over the last few years. It is Amrize's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amrize's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Amrize Net Income From Continuing Ops Regression Statistics

Arithmetic Mean 940,535,294
Geometric Mean 927,150,698
Coefficient Of Variation 18.82
Mean Deviation 137,696,886
Median 843,000,000
Standard Deviation 177,052,312
Sample Variance31347.5T
Range575M
R-Value 0.73
Mean Square Error15819.2T
R-Squared 0.53
Significance 0.001
Slope 25,450,490
Total Sum of Squares501560.3T

Amrize Net Income From Continuing Ops History

20261.2 B
20251.2 B
20241.4 B
2023955 M
20221.1 B

Stock Overview, Methodology & Data Sources

Amrize maintains exchange-traded status on the New York Stock Exchange. As a large-cap equity, Amrize is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/B of 2.43, profit margin of 10.03%. Amrize has a market cap of 32.87 B, ROE of 10.2%.

Methodology

Unless otherwise specified, financial data for Amrize is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Amrize (USA Stocks:AMRZ) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We reference public filings and market reference sources and regulatory disclosures, including those published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Data may be normalized and delayed in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Amrize is covered by 20 analysts. 10 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Evercore ISI, Morgan Stanley, BMO Capital Markets, Oppenheimer & Co., Guggenheim Securities, HSBC Global Research, Raymond James, Bernstein Research, Goldman Sachs, Wells Fargo Securities, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

More Resources for Amrize Stock Analysis

Reviewing Amrize commonly begins with financial statements and performance trends. Financial ratios provide context for profitability, efficiency, and growth trends. Selected reports below provide context for Amrize Stock:
Amrize Correlation provides competitor comparison context for Amrize. The view supports competitor context.
Our How to Buy Amrize Stock guide explains the steps to invest in Amrize stock.
Analysis related to Amrize should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
 Quarterly Earnings Growth
0.036
 Earnings Share
2.14
 Revenue Per Share
21.361
 Quarterly Revenue Growth
-0.004
 Return On Assets
0.0507
Investors evaluate Amrize using market value and book value, each describing different facets of the business. Amrize's market capitalization is 32.87 B. A P/B ratio of 2.43 indicates the market values Amrize above its accounting book value. Enterprise value stands at 36.57 B. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for Amrize differs from its quoted price, since each reflects a different lens. For Amrize, key inputs include a P/B ratio of 2.43, a profit margin of 10.03%, ROE of 10.2%, and revenue of 11.81 B. Trading price represents the transaction level agreed by market participants.